Perioperative Interstitial Brachytherapy for Soft Tissue Sarcomas: Prognostic Factors and Long-Term Results of 155 Patients

Author： Laskar Siddhartha Bahl Gaurav Puri Ajay Agarwal Manish Muckaden MaryAnn Patil Nikhilesh Jambhekar Nirmala Gupta Sudeep Deshpande Deepak Shrivastava Shyam Dinshaw Ketayun

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.14, Iss.2, 2007-02, pp. : 560-567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low dose-rate interstitial brachytherapy in soft tissue sarcomas

By Rosenblatt Edward Meushar Netanel Eidelman Mark Kuten Abraham

Sarcoma, Vol. 3, Iss. 2, 1999-09 ,pp. : 101-105

Informa Healthcare

Access to resources Recommend Favorite

Prognostic factors in soft tissue sarcomas: The Aarhus experience

By Vraa S. Keller J. Nielsen O.S. Sneppen O. Jurik A.G. Jensen O.M.

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1876-1882

Elsevier

Access to resources Recommend Favorite

Prognostic significance of CD155 mRNA expression in soft tissue sarcomas

Oncology Letters, Vol. 5, Iss. 6, 2013-01 ,pp. : 1771-1776

Spandidos Publications

Access to resources Recommend Favorite

Long-Term Results and Prognostic Factors in Patients with Epithelial Ovarian Cancer

By Brun J.-L. Feyler A. Chene G. Saurel J. Brun G. Hocke C.

Gynecologic Oncology, Vol. 78, Iss. 1, 2000-07 ,pp. : 21-27

Elsevier

Access to resources Recommend Favorite

Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults - long-term results of a phase II study

By Issels R.D. Abdel-Rahman S. Wendtner C.-M. Falk M.H. Kurze V. Sauer H. Aydemir U. Hiddemann W.

European Journal of Cancer, Vol. 37, Iss. 13, 2001-09 ,pp. : 1599-1608

Elsevier

Access to resources Recommend Favorite